pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis clinical isolates from the southeast region of Brazil
Author(s) -
Patricia Barco,
Rosilene Fressatti Cardoso,
Rosário Dominguez Crespo Hirata,
Clarice Queico Fujimura Leite,
J. R. C. Pandolfi,
Daisy Nakamura Sato,
M L Shikama,
Fabrício Freire de Melo,
Elsa Masae Mamizuka,
Paula Aline Zanetti Campanerut,
Mário Hiroyuki Hirata
Publication year - 2006
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkl363
Subject(s) - pyrazinamide , mycobacterium tuberculosis , microbiology and biotechnology , tuberculosis , biology , antibacterial agent , virology , mutation , gene , medicine , genetics , antibiotics , pathology
To investigate the presence of mutations in the pncA gene in 31 pyrazinamide-resistant Mycobacterium tuberculosis and 5 susceptible strains. MICs and pyrazinamidase (PZase) activity were also determined.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom